Targeted Radiopharmaceutical Therapy for Advanced Lung Cancer Phase I Trial of Rhenium Re 188 P2045, a Somatostatin Analog: Phase i trial of rhenium Re188 P2045, a somatostatin analog

Martin J. Edelman, Gerry Clamon, Daniel Kahn, Martin Magram, John Lister-James, Bruce R. Line

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Targeted Radiopharmaceutical Therapy for Advanced Lung Cancer Phase I Trial of Rhenium Re 188 P2045, a Somatostatin Analog: Phase i trial of rhenium Re188 P2045, a somatostatin analog'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science